92 related articles for article (PubMed ID: 10704696)
1. Serum levels of carboxy-terminal propeptide of human type I procollagen are an indicator for the progression of diabetic nephropathy in patients with type 2 diabetes mellitus.
Inukai T; Fujiwara Y; Tayama K; Aso Y; Takemura Y
Diabetes Res Clin Pract; 2000 Apr; 48(1):23-8. PubMed ID: 10704696
[TBL] [Abstract][Full Text] [Related]
2. [Serum carboxy-terminal propeptide of human type 1 procollagen (P1CP)].
Fujiwara Y; Takemura Y
Nihon Rinsho; 1998 Jan; 56 Suppl 3():269-72. PubMed ID: 9513428
[No Abstract] [Full Text] [Related]
3. Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.
Miyakawa M; Tsushima T; Demura H
Endocr J; 1996 Dec; 43(6):701-8. PubMed ID: 9075610
[TBL] [Abstract][Full Text] [Related]
4. [Measurement of serum concentration with radioimmunoassay for carboxyterminal propeptide of type 1 procollagen].
Yamamoto I; Takada M; Ohnaka Y; Yuu I; Yamamoto Y; Hamazu H; Morita R
Kaku Igaku; 1993 May; 30(5):563-9. PubMed ID: 8336416
[TBL] [Abstract][Full Text] [Related]
5. Correlation between Serum Bone Turnover Markers and Estimated Glomerular Filtration Rate in Chinese Patients with Diabetes.
Zhu X; Zhou Y; Hong S; Xue Y; Cui Y
Dis Markers; 2021; 2021():6731218. PubMed ID: 33505536
[TBL] [Abstract][Full Text] [Related]
6. Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis.
Kikuchi K; Ihn H; Sato S; Igarashi A; Soma Y; Ishibashi Y; Takehara K
Arch Dermatol Res; 1994; 286(2):77-80. PubMed ID: 8154928
[TBL] [Abstract][Full Text] [Related]
7. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.
Kikuchi K; Sato S; Kadono T; Ihn H; Takehara K
Arch Dermatol; 1994 Oct; 130(10):1269-72. PubMed ID: 7944508
[TBL] [Abstract][Full Text] [Related]
8. The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer.
Nakashima J; Sumitomo M; Miyajima A; Jitsukawa S; Saito S; Tachibana M; Murai M
J Urol; 1997 May; 157(5):1736-9. PubMed ID: 9112516
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa.
Collins VR; Dowse GK; Plehwe WE; Imo TT; Toelupe PM; Taylor HR; Zimmet PZ
Diabetes Care; 1995 Aug; 18(8):1140-9. PubMed ID: 7587849
[TBL] [Abstract][Full Text] [Related]
10. Elevated procollagen type I carboxyterminal propeptide production in cultured scleroderma fibroblasts.
Kikuchi K; Kadono T; Fujimoto M; Ihn H; Sato S; Takehara K
Dermatology; 1995; 190(2):104-8. PubMed ID: 7727830
[TBL] [Abstract][Full Text] [Related]
11. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria.
Fruehwald-Schultes B; Kern W; Beyer J; Forst T; Pfützner A; Peters A
Metabolism; 1999 Oct; 48(10):1290-3. PubMed ID: 10535393
[TBL] [Abstract][Full Text] [Related]
13. Serum type IV collagen in diabetic patients at risk for nephropathy.
Cohen MP; Shearman CW; Lautenslager GT
Diabetes Care; 2001 Aug; 24(8):1324-7. PubMed ID: 11473064
[TBL] [Abstract][Full Text] [Related]
14. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
Parving HH; Nielsen FS; Bang LE; Smidt UM; Svendsen TL; Chen JW; Gall MA; Rossing P
Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta in hypertensives with cardiorenal damage.
Laviades C; Varo N; Díez J
Hypertension; 2000 Oct; 36(4):517-22. PubMed ID: 11040229
[TBL] [Abstract][Full Text] [Related]
16. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
18. [Measurements and clinical usefulness of carboxyterminal propeptide of type I collagen and cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer].
Igawa T; Sakai H; Kanetake H; Saito Y
Hinyokika Kiyo; 1999 Apr; 45(4):235-9. PubMed ID: 10363141
[TBL] [Abstract][Full Text] [Related]
19. Assays of serum laminin and type III procollagen peptide for monitoring the clinical course of diabetic microangiopathy.
Okazaki R; Matsuoka K; Horiuchi A; Maruyama K; Okazaki I
Diabetes Res Clin Pract; 1988 Sep; 5(3):163-70. PubMed ID: 3219988
[TBL] [Abstract][Full Text] [Related]
20. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy.
Asakawa H; Tokunaga K; Kawakami F
J Diabetes Complications; 2000; 14(3):121-6. PubMed ID: 10989319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
